Pharma Transactional Due Diligence

Regulatory & Quality Risk Assessment

In-depth review of the target company's regulatory filings, inspection history, quality management system (QMS) maturity, and compliance status across all major global markets (FDA, EMA, etc.).

Operational & Technical Asset Valuation

Assessment of the target's manufacturing facilities, equipment state, capacity utilization, and technical viability to ensure the acquired assets meet future strategic and commercial needs.

Post-Acquisition Integration Strategy

Developing a clear, phased plan for the integration of regulatory dossiers, QMS, and manufacturing operations to ensure business continuity and maintain compliance post-transaction.